Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Deciphera Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Deciphera Pharmaceuticals

Deciphera Pharmaceuticals

Acquired

US-based Deciphera Pharmaceuticals develops kinase inhibitor treatments for various cancers globally.

HQ
Waltham, MA, US
Founded
2003
Overview
Compare
Fundraising
Employees
Website

Deciphera Pharmaceuticals, founded in Waltham, United States, is a biotechnology company dedicated to discovering and developing kinase inhibitor treatments for various types of cancer. Their core mission is to defeat cancer and improve the lives of patients globally. The company focuses on treating gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. Deciphera's product pipeline reflects their commitment to innovative cancer therapies.

Notable figures affiliated with Deciphera Pharmaceuticals include its team of experienced scientists and executives who have significantly contributed to oncology research. The company has attracted substantial investment from leading biotech investors. Key achievements include the development and approval of several kinase inhibitors that have shown promise in clinical trials. Deciphera's impact is evident in its contributions to cancer treatment advancements and its ongoing efforts to support patient communities worldwide.

Deciphera Pharmaceuticals - Similar Companies

Blueprint Medicines logo

Blueprint Medicines

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

BeOne Medicines logo

BeOne Medicines

beigene.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

Incyte logo

Incyte

incyte.com

Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

kiniksa.com

Verastem logo

Verastem

Revolution Medicines logo

Revolution Medicines

revmed.com

Traws Pharma logo

Traws Pharma

Clovis Oncology logo

Clovis Oncology

Accelerated Pharma logo

Accelerated Pharma

ImageneBio logo

ImageneBio

ikenaoncology.com

Syndax Pharmaceuticals logo

Syndax Pharmaceuticals

syndax.com

Seagen logo

Seagen

seagen.com

Foundation Medicine logo

Foundation Medicine

Deciphera Pharmaceuticals - Quick Facts

Who are Deciphera Pharmaceuticals' competitors?

Companies similar to Deciphera Pharmaceuticals include Blueprint Medicines, Karyopharm Therapeutics, BeOne Medicines and G1 Therapeutics.

When was Deciphera Pharmaceuticals founded?

Deciphera Pharmaceuticals was founded in 2003.

Where is Deciphera Pharmaceuticals' headquarters located?

Deciphera Pharmaceuticals' headquarters is located in Waltham, MA, US.

When was Deciphera Pharmaceuticals' last funding round?

Deciphera Pharmaceuticals' most recent funding round was for $125M (USD) in January 2023.

How much has Deciphera Pharmaceuticals raised to-date?

As of Jan 19, 2023, Deciphera Pharmaceuticals has raised a total of $1B (USD).

Deciphera Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Financial
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods
  • 7210Research and experimental development on natural sciences and engineering